· 个股论点

做多AEHR博弈存储与光子机会,MRVL因客户ASIC延期推迟至下半年建仓。

涉及标的:

中文翻译

我目前做多 $AEHR,以防三大存储巨头将其用于 HBM DRAM 裸片老化测试,或超大规模云厂商扩大 Sonoma 的使用。此外,硅光子学也是另一个关注领域。因此,这更像是一个投机性的“登月”选择,旨在观察其能否与 Advantest 和 $TER 竞争。至于 $MRVL,我喜欢它,但我认为更适合等到 2026 年下半年再建仓。有报道称 $MSFT Maia 路线图延迟了约半年,而 Marvell 预期的收入增长很大一部分依赖于该超大规模云厂商的特定 ASIC 项目。因此,我将在今年晚些时候重新评估它。

英文原文

I'm actually long $AEHR right now in the event any of the big three memory companies use them for HBM DRAM die burn in or hyperscalers expands Sonoma usage. Then there's silicon photonics, which is another area of interest. So it's more of a speculative moonshot pick to see if it can compete with Advantest and $TER. As for $MRVL, I like it but I find it more of a wait until H2 2026 long. There were reports $MSFT Maia faced roadmap longer delays by like half a year and a large part of marvell's expected revenue growth is tethered to this specific hyperscaler ASIC program. So I'll revisit it later on in the year.

在 X 上查看原推 ↗